07/09/2025
🌸 Advancing Menstrual Health: Scientific Innovations and MenSCs for Cell & Gene Therapy
Our research assistant recently attended this insightful seminar in Singapore, where experts from academia, industry, and femtech came together to discuss the future of menstrual blood-derived stem cells (MenSCs).
Some of the key learnings from the panel discussion include:
🔬 Scientific progress – MenSCs are being explored in preclinical and clinical studies for multiple sclerosis, lung injury, ovarian repair after chemotherapy, and more. However, challenges such as donor variability, standardized protocols, and scalability remain.
📚 Education & awareness – Dr. Ruby Huang highlighted how introducing menstrual health education at the university level helps normalize conversations and foster interdisciplinary problem-solving.
💡 Femtech ecosystem – Lindsay Davis emphasized the importance of building community and trust, as over half of women in Southeast Asia still find it difficult to openly discuss menstrual health.
🚀 Clinical & commercial potential – Dr. Badrul shared promising directions for MenSCs in regenerative medicine, from wound healing to neurodegenerative diseases, while stressing the need for regulatory clarity and collaboration.
📸 Pictured: Our research assistant with Dr. Badrul Isham which is one of the pioneering academicians who first wrote about menstrual stem cells in Malaysia. It was truly inspiring to meet a fellow Malaysian making significant contributions to this emerging field.
Attending this session reinforced the importance of interdisciplinary efforts and the exciting opportunities that MenSCs hold for advancing both science and women’s health.
We’re inspired by the progress in this field and look forward to contributing to the growing body of research and innovation in menstrual stem cell science.
